Letter from U.S. Senator Arlen Specter to Harold Varmus
Specter had recently appeared on a television show about alternative medicine, where two alternative medical practitioners
noted that saw palmetto (banned by FDA in 1990) wasn't included in NIH clinical trial for benign prostatic hypertrophy
-- he wanted to know why not. He also wondered about a recent Washington Post article about how research by corporations stifles
the exchange of scientific info. Varmus responded on May 6.
Item is a photocopy.
Number of Image Pages:
1 (88,988 Bytes)
1996-03-25 (March 25, 1996)
United States Senate. Committee on Appropriations
National Institutes of Health. Office of the Director
This item is in the public domain. It may be used without permission.
Medical Subject Headings (MeSH):
Basic Science and Congressional Politics: NIH Director, 1993-1999
Letter from Harold Varmus to U.S. Senator Arlen Specter (May 6, 1996)